Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 68.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 199.00
  • 52 Week Low: 68.50
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 15,000
  • Market Cap: £25.86m
  • Beta: 0.08

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.

1 Day Chart (20-09-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -200.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 5.7 n/a
Pr/Book 2.7  
Latest F'cast
Revenue 90.3% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AREC Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.70 (3.51) (17.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.16 (6.95) (27.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 2.40 (10.54) (32.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 4.57 (8.90) (28.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AREC Company Announcements

Notice of Results 19-Sep-2024 15:17 RNS
Arecor presents positive AT278 data at EASD 11-Sep-2024 07:00 RNS
Holding(s) in Company 22-Aug-2024 16:34 RNS

AREC ShareCast News

Arecor Therapeutics shares tank on funding update 10-Jun-2024 ShareCast
Arecor subsidiary Tetris launching Ogluo in the ... 29-Feb-2024 ShareCast
Arecor appoints new commercial manager to Tetris... 03-Jan-2024 ShareCast

Latest AREC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

AREC Market Data

Currency UK Pounds
Share Price 68.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 199.00
52 Week Low 68.50
Volume 15,000
Shares Issued 37.76m
Market Cap £25.86m
Beta 0.08

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.49% below the market average49.49% below the market average49.49% below the market average49.49% below the market average49.49% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Price Trend
88.67% below the market average88.67% below the market average88.67% below the market average88.67% below the market average88.67% below the market average
79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average
Income Not Available
Growth
57.07% above the market average57.07% above the market average57.07% above the market average57.07% above the market average57.07% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average

AREC Dividends

No dividends found

Trades for 20-Sep-2024

Time Volume / Share Price
14:53 7,500 @ 69.49p
14:48 2,500 @ 69.49p
14:13 5,000 @ 69.49p

AREC Key Personnel

CEO Sarah Jennifer Howell

Top of Page